midodrine has been researched along with Sex Disorders in 6 studies
Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To explore the effectiveness of various sources of self-stimulation, including oral midodrine, in triggering ejaculation in men with spinal cord injury (SCI), and to document the systematic variations in blood pressure at ejaculation and consider a revised definition of autonomic dysreflexia." | 3.74 | Blood pressure changes during sexual stimulation, ejaculation and midodrine treatment in men with spinal cord injury. ( Bélanger, M; Charvier, KF; Côté, M; Courtois, FJ; Leriche, A; Vézina, JG, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hadiji, N | 1 |
| Benbouzid, R | 1 |
| Previnaire, JG | 2 |
| Leblond, C | 1 |
| Mieusset, R | 1 |
| Enjalbert, M | 1 |
| Soler, JM | 3 |
| Courtois, FJ | 1 |
| Charvier, KF | 1 |
| Leriche, A | 1 |
| Vézina, JG | 1 |
| Côté, M | 1 |
| Bélanger, M | 1 |
| Schwale, M | 1 |
| Frosch, P | 1 |
| Tölle, E | 1 |
| Niermann, H | 1 |
| Jonas, D | 1 |
| Linzbach, P | 1 |
| Weber, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Dose Response to the Norepinephrine Precursor Droxidopa in Hypotensive Individuals With Spinal Cord Injury[NCT03602014] | Phase 4 | 22 participants (Actual) | Interventional | 2018-06-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 other studies available for midodrine and Sex Disorders
| Article | Year |
|---|---|
[Evaluation of the management of erectile and ejaculatory dysfunction in a series of 90 patients with spinal cord injuries].
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Aged; Alprostadil; Ejaculation; Erectile Dysfunction; | 2013 |
Ejaculatory dysfunction in spinal cord injury men is suggestive of dyssynergic ejaculation.
Topics: Ejaculation; Humans; Male; Midodrine; Sexual Dysfunction, Physiological; Spinal Cord Injuries; Vasoc | 2011 |
[Treatment of ejaculation disorders].
Topics: Adrenergic alpha-Agonists; Ejaculation; Humans; Male; Midodrine; Sexual Dysfunction, Physiological | 2005 |
Blood pressure changes during sexual stimulation, ejaculation and midodrine treatment in men with spinal cord injury.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Aged; Autonomic Dysreflexia; Blood Pressure; Ejaculati | 2008 |
[Treatment of retrograde ejaculation and anorgasm with an alpha-sympathomimetic agent (Midodrin)].
Topics: Adult; Ejaculation; Ethanolamines; Female; Humans; Male; Midodrine; Orgasm; Sexual Dysfunction, Phys | 1980 |
The use of Midodrin in the treatment of ejaculation disorders following retroperitoneal lymphadenectomy.
Topics: Adult; Aorta; Ejaculation; Ethanolamines; Female; Humans; Iliac Artery; Lymph Node Excision; Male; M | 1979 |